Devices

In part 3 of this Exclusive Interview, Scott Abbott explains how to adjust the insulin dosage using the V-Go insulin delivery system in a talk with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 4 of this Exclusive Interview, Scott Abbott talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about how studies have proven the effectiveness of the V-Go device.

In part 5 of this Exclusive Interview, Scott Abbott talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about the other benefits of using the V-Go system.

In part 6 of this Exclusive Interview, Scott Abbott talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the positive factors of V-Go and the patients who can use it.

In part 7 of this Exclusive Interview, Scott Abbott shares what's next on the V-Go front in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

Dr. Stuart Weiss discusses preferred diabetes medications and new diabetes technologies, such as CGMs.

In part 4 of this Exclusive Interview, Dr. Stuart Weiss talks with Diabetes in Control Publisher Steve Freed during the AACE meeting in Austin, Texas about his experiences with diabetes technology.

In this Exclusive Interview, Dr. Stuart Weiss talks with Diabetes in Control Publisher Steve Freed during the AACE meeting in Austin, Texas about the good and challenges with CGMs.

Why Google, Apple, and Amazon entering the diabetes market is the real big story from ADA.

Guest writer David Kliff of Diabetic Investor explains why he doesn't expect any closed-loop systems to expand the overall insulin pump market by any significant amount.